Study guide
11.1 Premalignant Lesions & Oral Cancer
MFDS Part 1 Membership of the Faculty of Dental Surgery
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
Current Exam Facts How to Use This Guide Eligibility, Booking & the MFDS Pathway
2 Basic Sciences, History Taking & Clinical Assessment
1.1 Head & Neck Anatomy and Underpinning Basic Sciences 1.2 History Taking, Communication & Clinical Examination 1.3 Special Tests, Investigations & Diagnostic Accuracy 1.4 Differential Diagnosis, Triage & When to Biopsy 1.5 Dental Anomalies & Developmental Conditions
3 Cariology, Operative Dentistry & Endodontics
2.1 Cariology & Caries Diagnosis 2.2 Caries Management & Prevention 2.3 Operative Dentistry & Cavity Preparation 2.4 Endodontics 2.5 Tooth Surface Loss & Tooth Discolouration
4 Periodontology & Prosthodontics
3.1 Periodontology 3.2 Fixed Prosthodontics 3.3 Removable Prosthodontics 3.4 Occlusion & Occlusal Assessment
5 Paediatric Dentistry, Orthodontics & Dental Trauma
4.1 Paediatric Dentistry 4.2 Orthodontics 4.3 Dental Trauma 4.4 Orthodontic Assessment, Indices & Referral 4.5 Impacted Teeth & Radiographic Localisation
6 Oral Surgery, Treatment Planning & Prevention
5.1 Oral Surgery & Extractions 5.2 Treatment Planning & Patient Management 5.3 Prevention & Health Promotion
7 Cardiovascular, Respiratory & Endocrine Disease
6.1 Cardiovascular Disease 6.2 Respiratory Disease 6.3 Endocrine Disease & Diabetes 6.4 Bleeding Disorders & Anticoagulation
8 Haematology, Infection & the Medically Compromised Patient
7.1 Haematology 7.2 Infectious Disease 7.3 The Medically Compromised Patient 7.4 Neurological & Gastrointestinal Disease
9 Medical Emergencies in Dental Practice
8.1 Medical Emergencies & Resuscitation 8.2 Anaphylaxis & Acute Allergy 8.3 Emergency Drugs & the Resuscitation Kit
10 Special Care Dentistry, Mental Health & Anxiety Management
9.1 Special Care Dentistry & Patients with Disability 9.2 Mental Health & Behavioural Science 9.3 Dental Anxiety & Behaviour Management
11 Oral Medicine — Mucosal Disease & Orofacial Pain
10.1 Oral Mucosal Disease & Lichen Planus 10.2 Vesiculobullous & Ulcerative Disorders 10.3 Candidiasis & Fungal Infections 10.4 Orofacial Pain & Neuropathic Disorders
12 Oral Pathology — Lesions, Cysts, Tumours & Salivary Glands
11.1 Premalignant Lesions & Oral Cancer 11.2 Odontogenic Cysts 11.3 Odontogenic & Non-Odontogenic Tumours 11.4 Salivary Gland Disease
13 Pharmacology — Local Anaesthesia, Analgesia & Sedation
12.1 Local Anaesthesia 12.2 Analgesics & NSAIDs 12.3 Conscious Sedation
14 Pharmacology — Antimicrobials, Prescribing & Drug Interactions
13.1 Antimicrobials & Antibiotic Stewardship 13.2 Prescribing & Drug Interactions
15 Dental Materials
14.1 Properties & Testing of Dental Materials 14.2 Amalgam & Metal Restorations 14.3 Composite Resin & Adhesive Dentistry 14.4 Impression Materials, Cements & Other Materials
16 Microbiology, Infection Control & Radiology
15.1 Oral Microbiology & Infection Control 15.2 Dental Radiology & Imaging 15.3 Radiation Protection
17 Law, Ethics, Professionalism & Evidence-Based Dentistry
16.1 Consent & Confidentiality 16.2 GDC Standards & Professionalism 16.3 Safeguarding & Duty of Candour 16.4 Evidence-Based Dentistry & Research Methods 16.5 Records, Information Governance & Regulation 16.6 Communication, Teamworking, Human Factors & Raising Concerns
18 Statistics, Dental Public Health, Critical Appraisal & Exam Strategy
17.1 Statistics & Critical Appraisal 17.2 Dental Public Health & Epidemiology 17.3 SBA Technique & Exam Strategy 17.4 Final Review & Key Points
11.1 Premalignant Lesions & Oral Cancer
Key Takeaways Explain This Topic AI
NICE NG12 requires a suspected cancer pathway referral (2-week wait) for any unexplained oral ulceration lasting more than 3 weeks, and for persistent unexplained red/red-white patches or neck lumps
Erythroplakia has the highest malignant transformation of any oral potentially malignant disorder (around 30–50% in meta-analyses, with ~40% already invasive at first biopsy)
Oral epithelial dysplasia is graded mild, moderate or severe using both architectural and cytological atypia; severe dysplasia involving the full epithelial thickness is carcinoma in situ
In the UK the lateral border of the tongue is the most common intra-oral site for OSCC, followed by the floor of mouth
The 8th edition AJCC/UICC TNM staging for oral cavity cancer incorporates depth of invasion (DOI) in addition to maximum tumour diameter
Last updated: August 2026
Oral Potentially Malignant Disorders (OPMDs)
An oral potentially malignant disorder (OPMD) is a mucosal disorder in which an increased risk of oral squamous cell carcinoma (OSCC) exists compared with normal mucosa. MFDS Part 1 expects you to recognise the common OPMDs, grade dysplasia, and quote approximate malignant transformation (MT) rates.
Oral Epithelial Dysplasia
Dysplasia is the abnormal maturation of the epithelium graded on combined architectural and cytological atypia (the WHO three-tier system remains in routine UK use).
- Grade Architectural features Cytological features Approx MT risk
- Mild Basal cell hyperplasia Atypia confined to lower third ~7%
- Moderate Drop-shaped rete ridges Atypia into middle third ~11%
- Severe Loss of stratification, keratin pearls Atypia into upper third, pleomorphism, hyperchromasia ~17%
Carcinoma in situ = severe dysplasia involving the full epithelial thickness without breach of the basement membrane. Once the basement membrane is breached, the lesion is invasive carcinoma.
Leukoplakia
Leukoplakia is a white plaque that cannot be rubbed off and cannot be characterised as any other diagnosable disease. Two clinical subtypes:
Homogeneous — flat, uniform white plaque, lower MT risk.
Non-homogeneous — speckled, nodular, verrucous; higher MT risk.
Proliferative verrucous leukoplakia (PVL) is a rare, multifocal, recurrent, slow-growing verrucous white lesion with a markedly high MT rate (around 50% in case series) — managed in an oral medicine / head and neck MDT setting.
Erythroplakia
Erythroplakia is a fiery red, velvety patch that cannot be attributed to another diagnosis. It has the highest MT rate of any OPMD — meta-analyses report around 30–50%, and roughly 40% of lesions are already invasive carcinoma at first biopsy. Erythroplakia mandates urgent biopsy.
Other OPMDs
Oral submucous fibrosis (OSMF) — caused by areca/betel nut chewing; progressive submucosal fibrosis produces restricted mouth opening and palpable fibrous bands; MT around 5%.
Oral lichen planus — reticular (Wickham striae), atrophic, erosive forms; erosive/atrophic variants carry higher risk; overall MT around 1%.
Actinic keratosis (actinic cheilitis) — lower lip of outdoor workers from chronic UV exposure; can progress to SCC of the lip.
MFDS clinical rule: Red patch, non-homogeneous white patch, ulcer lasting >3 weeks, or persistent lump — biopsy or refer under the suspected cancer pathway. Do not reassure.